Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Revenue, net:
Core companion animal health	$ 20,983	$ 16,371	$ 61,312	$ 51,223
Other vaccines, pharmaceuticals and products	7,051	5,434	13,526	14,291
Total revenue, net	28,034	21,805	74,838	65,514
Cost of revenue	16,437	13,488	42,860	39,841
Gross profit	11,597	8,317	31,978	25,673
Operating expenses:
Selling and marketing	5,173	4,716	15,872	14,413
Research and development	493	322	1,304	1,084
General and administrative	3,789	2,938	9,810	9,019
Total operating expenses	9,455	7,976	26,986	24,516
Operating income	2,142	341	4,992	1,157
Interest and other (income) expense, net	(69)	(40)	105	(31)
Income before income taxes	2,211	381	4,887	1,188
Income tax expense:
Current tax expense	106	60	232	113
Deferred tax expense	722	306	1,511	555
Total income tax expense	828	366	1,743	668
Net income	1,383	15	3,144	520
Net income (loss) attributable to non-controlling interest	(32)	(498)	(66)	(1,254)
Net income attributable to Heska Corporation	$ 1,415	$ 513	$ 3,210	$ 1,774
Basic net income per share attributable to Heska Corporation	$ 0.22	$ 0.09	$ 0.51	$ 0.30
Diluted net income per share attributable to Heska Corporation	$ 0.20	$ 0.08	$ 0.46	$ 0.28
Weighted average outstanding shares used to compute basic net income per share attributable to Heska Corp.	6,344	5,989	6,270	5,929
Weighted average outstanding shares used to compute diluted net income per share attributable to Heska Corp	7,139	6,554	7,041	6,314